secwatch / observer
8-K filed May 5, 2026, 7:59 PM ET ticker SGRY CIK 0001638833
earnings confidence high sentiment neutral materiality 0.60

Surgery Partners Q1 revenue $810.9M (+4.5%), net loss $35.9M; reaffirms FY guidance

Surgery Partners, Inc.

2026-Q1 EPS reported -$0.28 revenue$810,900,000

Key facts

Extracted from this filing and checked against the source text.

Earnings Releases SEC 8-K Item 2.02 confidence 0.98

Surgery Partners, Inc. reported Full year 2026 results: revenue $3.35 billion to $3.45 billion. Guidance reaffirmed.

Period
Full year 2026
Revenue
$3.35 billion to $3.45 billion
Guidance
reaffirmed
Result
guidance update
Exact text from the filing
The Company reaffirmed its outlook for 2026 revenues to be in the range of $3.35 billion to $3.45 billion and Adjusted EBITDA of at least $530 million.
View on SEC.gov
Earnings Releases SEC 8-K Item 2.02 confidence 0.98

Surgery Partners, Inc. reported first quarter ended March 31, 2026 results: revenue $810.9 million, net income $35.9 million. Guidance reaffirmed.

Period
first quarter ended March 31, 2026
Revenue
$810.9 million
Net income
$35.9 million
Guidance
reaffirmed
Result
reported results
Exact text from the filing
return the business to consistent growth, while delivering on long-term shareholder value.” First Quarter 2026 Results Revenues for the first quarter of 2026 increased 4.5% to $810.9 million compared to $776.0 million for the first quarter of 2025. Same-facility revenues for the first quarter of 2026 increased 4.4% as compared to the same period in prior year, with a
View on SEC.gov

Browse all earnings releases →

Surgery Partners, Inc. filing history →

Source: SEC EDGAR
accession 0001638833-26-000044
Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.